Continuing Education

Renal Function Assessment and Direct-Acting Oral Anticoagulants Dosing: Are We Entering a New Age?

June 3, 2021 Editor

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

← Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different mates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries
Patient Access Preferences Report: The Pandemic’s Lasting Impact →